CIRS Group has compiled and summarized the latest global cosmetics regulatory developments in April 2026, covering industry news, new regulations, policy adjustments, and regulatory trends, helping companies stay compliant and fully informed of the evolving global cosmetics regulatory landscape.
Globally, the regulatory landscape for exosome cosmetics exhibits significant variability. This article systematically reviews the management measures, regulations, and ethical standards concerning exosome cosmetics in various countries/regions, including the United States, the European Union, Japan, South Korea, Taiwan, and mainland China. It explores the context of compliance and prohibitions, as well as their impact on industry development, providing comprehensive global regulatory compliance guidance for cosmetic companies.
On January 9, 2026, the Malaysian Medical Device Authority (MDA) issued the Medical Device (Prescribed Medical Device) Order 2026, aimed at strengthening the regulation of medical devices used for aesthetic and cosmetic purposes to ensure consumer safety and protection. The regulation is scheduled to come into effect on June 1, 2026.
On January 21, 2026, the New Zealand Environmental Protection Authority (EPA) announced that the updated rules for importing and manufacturing cosmetic products had come into effect on 1 January 2026. All cosmetic products that contain a hazardous ingredient must comply with the updated rules for cosmetics (some changes take effect later).
This article compiles and summarizes the latest developments in cosmetics regulations in China and globally as of November 2025, covering industry news, newly issued regulations, latest standards updates, relevant policy adjustments, and regulatory requirements. It aims to assist enterprises in ensuring compliance and keeping up with global cosmetics regulatory trends.
This article compiles and summarizes the latest developments in cosmetics regulations in China and globally as of October 2025, covering industry news, newly issued regulations, relevant policy adjustments, and regulatory requirements. It aims to assist enterprises in ensuring compliance and keeping up with global cosmetics regulatory trends.
This article compiles and summarizes the latest developments in cosmetics regulations in China and globally as of September 2025, covering industry news, newly issued regulations, relevant policy adjustments, and regulatory requirements. It aims to assist enterprises in ensuring compliance and keeping up with global cosmetics regulatory trends.
Recently, the Indonesia Food and Drug Authority (BPOM) has canceled the distribution permits for 21 cosmetic products. The decision was made due to discrepancies between the actual ingredients and the information declared on the product labels, indicating non-compliance with labeling regulations.
This article compiles and summarizes the latest developments in cosmetics regulations in China and globally as of August 2025, covering industry news, newly issued regulations, relevant policy adjustments, and regulatory requirements. It aims to assist enterprises in ensuring compliance and keeping up with global cosmetics regulatory trends.
In November 2024, the Indonesian Food and Drug Authority (BPOM) introduced new provisions under Regulation No. 18/2024, governing the labeling, promotion, and advertising of all cosmetic products in Indonesia. The regulation came into effect on November 15, 2024. A 12-month transitional period has been granted to holders of cosmetic distribution licenses that were obtained prior to the effective date, requiring full compliance with the new requirements by November 15, 2025. Relevant companies are advised to pay close attention to the transition timeline and ensure product compliance with the new regulation.
